Security Snapshot

AtriCure, Inc. - Common Stock (ATRC) Institutional Ownership

CUSIP: 04963C209

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

163

Shares (Excl. Options)

20.07MFull value: 20,065,782 · shares · 30 Sep 2026

Price

$56.20

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
-1,478,462
Value change
-$51,467,553
Number of holders
163
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
50,918,324
SEC-reported price per share
$57.28
Insider filing price
$57.28
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • ATRC - AtriCure, Inc. - Common Stock is tracked under CUSIP 04963C209.
  • 163 institutions reported positions in Q3 2026.
  • 8 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 251 to 163 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $1.47BFull value: $1,467,697,673 · USD · 30 Jun 2026
    to
    $1.13BFull value: $1,128,884,435 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 163 institutions filings for Q3 2026.

Open SEC evidence

Security key

04963C209

13F reference period

Q3 2026

13F holders

163

13D/G owners

8

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
8
Security
ATRC
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 15% +95% $415,621,777 +$210,775,530 7,837,484 +103% BlackRock, Inc. 30 Sep 2026
VANGUARD PORTFOLIO MANAGEMENT LLC 7.2% +28% $206,608,229 +$52,356,932 3,676,303 +34% Vanguard Portfolio Management 30 Sep 2026
WELLINGTON MANAGEMENT GROUP LLP 6.8% -15% $96,504,294 -$16,738,950 3,382,555 -15% Wellington Management Group LLP 31 Mar 2026
Hood River Capital Management LLC 6.2% +3.8% $122,501,931 +$6,839,133 3,096,611 +5.9% Hood River Capital Management LLC 31 Dec 2025
ALLIANCEBERNSTEIN L.P. 5.5% $89,667,342 2,768,365 AllianceBernstein L.P. 30 Jun 2026
VANGUARD CAPITAL MANAGEMENT LLC 5.1% $72,265,491 2,532,965 Vanguard Capital Management 31 Mar 2026
MACQUARIE GROUP LTD 4.6% -9.2% $80,700,257 -$7,537,719 2,289,369 -8.5% Macquarie Group Limited 30 Sep 2025
Champlain Investment Partners, LLC 4.4% -22% $71,407,964 -$21,803,353 2,137,963 -23% Champlain Investment Partners, LLC 31 Mar 2025
As of 30 Sep 2026, 163 institutional investors reported holding
20.07MFull value: 20,065,782 · shares · 30 Sep 2026
shares of AtriCure, Inc. - Common Stock (ATRC). This represents 39% of the company’s total
50.92MFull value: 50,918,324 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
50%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
WELLINGTON MANAGEMENT GROUP LLP 8.1% 4,116,204 +18% 0.04% $231,330,666
VANGUARD PORTFOLIO MANAGEMENT LLC 7.1% 3,626,996 +16% 0.01% $203,837,175
Hood River Capital Management LLC 5.6% 2,842,552 -2.2% 1.4% $159,751,422
VANGUARD CAPITAL MANAGEMENT LLC 4.3% 2,193,627 +0.15% 0% $123,281,837
STATE STREET CORP 4.2% 2,128,807 +53% 0% $119,638,953
GEODE CAPITAL MANAGEMENT, LLC 2.6% 1,303,089 -1.3% 0% $73,248,248
DIMENSIONAL FUND ADVISORS LP 2% 1,021,214 -2.2% 0.01% $57,400,501
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 1.8% 939,607 -28% 0.02% $52,805,913
BANK OF AMERICA CORP /DE/ 1.8% 930,295 +6.4% 0% $52,282,579
NEUBERGER BERMAN GROUP LLC 1.7% 850,256 -10% 0.03% $47,859,099
KENNEDY CAPITAL MANAGEMENT LLC 1.4% 698,242 -19% 0.74% $39,241,200
MORGAN STANLEY 0.97% 493,042 +7.7% 0% $27,709,060
Champlain Investment Partners, LLC 0.92% 466,167 -50% 0.9% $26,198,585
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 0.91% 461,637 -20% 0.01% $25,944,000
Driehaus Capital Management LLC 0.78% 394,664 0.15% $22,180,117
PANAGORA ASSET MANAGEMENT INC 0.76% 386,569 -0.65% 0.07% $21,725,178
VANGUARD FIDUCIARY TRUST CO 0.71% 359,662 +0.17% 0% $20,213,004
WCM INVESTMENT MANAGEMENT, LLC 0.63% 322,837 -8% 0.03% $18,740,688
RENAISSANCE TECHNOLOGIES LLC 0.63% 321,000 +37% 0.02% $18,040,200
First Eagle Investment Management, LLC 0.57% 289,343 -2.8% 0.03% $16,261,077
OSTERWEIS CAPITAL MANAGEMENT INC 0.55% 278,695 -44% 0.78% $15,662,659
Public Sector Pension Investment Board 0.51% 259,000 0.03% $14,845,880
Invesco Ltd. 0.51% 257,288 +203% 0% $14,459,585
Amundi 0.46% 235,690 -11% 0% $13,245,778
RAYMOND JAMES FINANCIAL INC 0.43% 220,525 -17% 0% $12,393,504

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
51
Headline period
Q3 2026
Rows shown
1-25 of 51
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 20,065,782 $1,128,884,435 -$51,467,553 $56.20 163
2026 Q2 52,368,444 $1,467,697,673 +$65,571,310 $27.98 251
2026 Q1 50,021,272 $1,462,827,790 -$2,007,691 $28.53 222
2025 Q4 48,743,756 $1,928,695,662 -$52,107,022 $39.56 234
2025 Q3 48,137,442 $1,696,572,476 -$26,346,560 $35.25 219
2025 Q2 48,899,026 $1,601,933,467 -$39,427,096 $32.77 197
2025 Q1 50,269,592 $1,621,969,076 +$127,818,413 $32.26 217
2024 Q4 46,483,344 $1,421,304,781 -$87,630,696 $30.56 209
2024 Q3 49,264,286 $1,381,109,066 -$12,223,311 $28.04 198
2024 Q2 50,723,505 $1,155,009,424 +$19,813,566 $22.77 194
2024 Q1 49,351,679 $1,501,026,424 +$67,021,576 $30.42 218
2023 Q4 47,164,039 $1,683,028,664 +$48,077,369 $35.69 230
2023 Q3 45,425,624 $1,988,207,852 +$14,251,801 $43.80 224
2023 Q2 45,005,948 $2,219,137,443 +$14,004,669 $49.36 219
2023 Q1 44,806,862 $1,857,210,760 -$5,467,106 $41.45 219
2022 Q4 44,912,321 $1,992,625,452 +$11,085,452 $44.38 207
2022 Q3 44,732,086 $1,747,349,909 -$40,042,063 $39.10 201
2022 Q2 44,464,969 $1,816,797,154 +$5,915,882 $40.86 196
2022 Q1 44,016,086 $2,889,958,812 -$4,881,515 $65.67 206
2021 Q4 44,091,364 $3,064,833,086 +$50,071,000 $69.53 211
2021 Q3 43,335,200 $3,014,938,884 -$67,863,474 $69.55 206
2021 Q2 44,284,173 $3,513,197,655 -$20,715,510 $79.33 206
2021 Q1 44,587,200 $2,919,424,135 +$101,599,138 $65.52 184
2020 Q4 44,006,691 $2,449,180,355 +$92,888,778 $55.67 191
2020 Q3 42,560,668 $1,698,181,209 +$16,788,166 $39.90 178
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .